[HTML][HTML] The curious case of the HepG2 cell line: 40 years of expertise

VA Arzumanian, OI Kiseleva… - International journal of …, 2021 - mdpi.com
Liver cancer is the third leading cause of cancer death worldwide. Representing such a
dramatic impact on our lives, liver cancer is a significant public health concern. Sustainable …

Wnt–β-catenin signalling in liver development, health and disease

MJ Perugorria, P Olaizola, I Labiano… - Nature reviews …, 2019 - nature.com
The canonical Wnt–β-catenin pathway is a complex, evolutionarily conserved signalling
mechanism that regulates fundamental physiological and pathological processes. Wnt–β …

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

Y Jiang, A Sun, Y Zhao, W Ying, H Sun, X Yang, B Xing… - Nature, 2019 - nature.com
Hepatocellular carcinoma is the third leading cause of deaths from cancer worldwide.
Infection with the hepatitis B virus is one of the leading risk factors for developing …

Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: a meta-analysis of randomized phase III trials

R Jackson, EE Psarelli, S Berhane, H Khan… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Following the Sorafenib Hepatocellular Carcinoma Assessment Randomized
Protocol (SHARP) trial, sorafenib has become the standard of care for patients with …

[HTML][HTML] Genetic alterations in hepatocellular carcinoma: An update

ZS Niu, XJ Niu, WH Wang - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. Although recent advances in therapeutic approaches for treating HCC have …

Obesity-associated mechanisms of hepatocarcinogenesis

R Karagozian, Z Derdák, G Baffy - Metabolism, 2014 - Elsevier
Obesity has been recognized as a key component of the metabolic syndrome, a cluster of
risk factors associated with diabetes and cardiovascular morbidity. In addition, obesity has …

[HTML][HTML] Human oncoviruses and p53 tumor suppressor pathway deregulation at the origin of human cancers

ML Tornesello, C Annunziata, AL Tornesello… - Cancers, 2018 - mdpi.com
Viral oncogenesis is a multistep process largely depending on the complex interplay
between viruses and host factors. The oncoviruses are capable of subverting the cell …

[HTML][HTML] Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy

XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the third most frequent cause of tumor-related mortality
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …

miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features

Y Gu, X Wei, Y Sun, H Gao, X Zheng, LL Wong, L Jin… - Cancer research, 2019 - AACR
Various cancer stem cell (CSC) biomarkers have been identified for hepatocellular
carcinoma (HCC), but little is known about the implications of heterogeneity and shared …

Genomic insights into WNT/β-catenin signaling

J Rosenbluh, X Wang, WC Hahn - Trends in pharmacological sciences, 2014 - cell.com
The canonical WNT pathway regulates the stability of the proto-oncogene β-catenin and is
aberrantly activated in many cancer types. Studies in a wide range of experimental models …